Mark G. Lebwohl MDProfessor and Chairman, Department of Dermatology, Mount Sinai School of Medicine, New York, New York
Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai.
Dr. Lebwohl has been practicing dermatology since 1983. He is professor and chairman of the Department of Dermatology of The Mount Sinai School of Medicine. Dr. Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl has served as chairman of the Psoriasis Task Force of the American Academy of Dermatology, and has directed the AAD’s annual Psoriasis Symposium, Diagnostic Update Symposium and Therapeutics Symposium. He was a member of the Scientific Assembly Council, and chaired Academy 2001 in California and the AAD annual meeting in Washington, D.C. in 2004. He was elected to the Board of Directors of the AAD for 2010-2014. Dr. Lebwohl is the 2014-15 President- Elect of the American Academy of Dermatology, and will serve as the AAD President in 2015-16.
Dr. Lebwohl is chairman of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum and has been medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He is on the editorial board of the Journal of the American Academy of Dermatology and is editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine. Dr. Lebwohl has chaired numerous symposia and has written, edited, or co-edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease. The second edition of The Skin and Systemic Disease has been published in English and in French, and English, Portuguese, and Polish versions of Treatment of Skin Disease have been published. Other books include Difficult Diagnoses in Dermatology, Psoriasis, Mild-to-Moderate Psoriasis and Moderate-to-Severe Psoriasis. He has authored or co-authored over 500 publications including peer-reviewed articles, invited articles and book chapters. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.
Recent Contributions to PracticeUpdate:
- Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of COVID-19
- Should Biologics for Psoriasis Be Interrupted in the Era of COVID-19?
- Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients
- Maintenance of Skin Clearance With Ixekizumab Treatment of Psoriasis
- Psoriasis Patients on TNF-α Inhibitors Have Lower Cardiovascular Risk Than Those Receiving Phototherapy
- Novel Topical Liposomal Formulation of Cyclosporine for Plaque Psoriasis
- Physician Perceptions and Experience of Treatment in Actinic Keratosis